<SEC-DOCUMENT>0001950047-25-004736.txt : 20250701
<SEC-HEADER>0001950047-25-004736.hdr.sgml : 20250701
<ACCEPTANCE-DATETIME>20250701161620
ACCESSION NUMBER:		0001950047-25-004736
CONFORMED SUBMISSION TYPE:	144
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20250701
DATE AS OF CHANGE:		20250701

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ATAI Life Sciences N.V.
		CENTRAL INDEX KEY:			0001840904
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			P7
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		144
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	001-40493
		FILM NUMBER:		251096553

	BUSINESS ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		PROF. J.H. BAVINCKLAAN 7
		CITY:			AMSTELVEEN
		PROVINCE COUNTRY:   	P7
		ZIP:			1183
		BUSINESS PHONE:		49 89 2153 9035

	MAIL ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		PROF. J.H. BAVINCKLAAN 7
		CITY:			AMSTELVEEN
		PROVINCE COUNTRY:   	P7
		ZIP:			1183

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ATAI Life Sciences B.V.
		DATE OF NAME CHANGE:	20210115

REPORTING-OWNER:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Kirpekar Sahil
		CENTRAL INDEX KEY:			0001951712
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		144

	MAIL ADDRESS:	
		STREET 1:		C/O ATAI LIFE SCIENCES N.V.
		STREET 2:		WALLSTRASSE 16
		CITY:			BERLIN
		STATE:			2M
		ZIP:			10179
</SEC-HEADER>
<DOCUMENT>
<TYPE>144
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:ns2="http://www.sec.gov/edgar/common">
    <headerData>
        <submissionType>144</submissionType>
        <filerInfo>
            <filer>
                <filerCredentials>
                    <cik>0001951712</cik>
                    <ccc>XXXXXXXX</ccc>
                </filerCredentials>
            </filer>
            <liveTestFlag>LIVE</liveTestFlag>



        </filerInfo>
    </headerData>
    <formData>
        <issuerInfo>
            <issuerCik>0001840904</issuerCik>
            <issuerName>ATAI LIFE SCIENCES N.V.</issuerName>
            <secFileNumber>001-40493</secFileNumber>
            <issuerAddress>
                <ns2:street1>Wallstrasse 16</ns2:street1>
                <ns2:city>Berlin</ns2:city>
                <ns2:stateOrCountry>2M</ns2:stateOrCountry>
                <ns2:zipCode>10179</ns2:zipCode>
            </issuerAddress>
            <issuerContactPhone>49 89 2153 9035</issuerContactPhone>
            <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>SAHIL KIRPEKAR</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
            <relationshipsToIssuer>
                <relationshipToIssuer>Officer</relationshipToIssuer>
            </relationshipsToIssuer>
        </issuerInfo>
        <securitiesInformation>
            <securitiesClassTitle>Common</securitiesClassTitle>
            <brokerOrMarketmakerDetails>
                <name>Morgan Stanley Smith Barney LLC Executive Financial Services</name>
                <address>
                    <ns2:street1>1 New York Plaza</ns2:street1>
                    <ns2:street2>8th Floor</ns2:street2>
                    <ns2:city>New York</ns2:city>
                    <ns2:stateOrCountry>NY</ns2:stateOrCountry>
                    <ns2:zipCode>10004</ns2:zipCode>
                </address>
            </brokerOrMarketmakerDetails>
            <noOfUnitsSold>106093</noOfUnitsSold>
            <aggregateMarketValue>294380.54</aggregateMarketValue>
            <noOfUnitsOutstanding>200377609</noOfUnitsOutstanding>
            <approxSaleDate>07/01/2025</approxSaleDate>
            <securitiesExchangeName>NASDAQ</securitiesExchangeName>
        </securitiesInformation>
        <securitiesToBeSold>
            <securitiesClassTitle>Common</securitiesClassTitle>
            <acquiredDate>07/01/2025</acquiredDate>
            <natureOfAcquisitionTransaction>Exercise of options under a registered plan</natureOfAcquisitionTransaction>
            <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
            <isGiftTransaction>N</isGiftTransaction>
            <amountOfSecuritiesAcquired>40000</amountOfSecuritiesAcquired>
            <paymentDate>06/27/2025</paymentDate>
            <natureOfPayment>Cash</natureOfPayment>
        </securitiesToBeSold>
        <securitiesToBeSold>
            <securitiesClassTitle>Common</securitiesClassTitle>
            <acquiredDate>07/01/2025</acquiredDate>
            <natureOfAcquisitionTransaction>Exercise of options under a registered plan</natureOfAcquisitionTransaction>
            <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
            <isGiftTransaction>N</isGiftTransaction>
            <amountOfSecuritiesAcquired>66093</amountOfSecuritiesAcquired>
            <paymentDate>06/27/2025</paymentDate>
            <natureOfPayment>Cash</natureOfPayment>
        </securitiesToBeSold>
        <nothingToReportFlagOnSecuritiesSoldInPast3Months>N</nothingToReportFlagOnSecuritiesSoldInPast3Months>
        <securitiesSoldInPast3Months>
            <sellerDetails>
                <name>SAHIL KIRPEKAR</name>
                <address>
                    <ns2:street1>Wallstrasse 16</ns2:street1>
                    <ns2:city>Berlin</ns2:city>
                    <ns2:stateOrCountry>2M</ns2:stateOrCountry>
                    <ns2:zipCode>10179</ns2:zipCode>
                </address>
            </sellerDetails>
            <securitiesClassTitle>Common</securitiesClassTitle>
            <saleDate>06/04/2025</saleDate>
            <amountOfSecuritiesSold>80000</amountOfSecuritiesSold>
            <grossProceeds>198408.00</grossProceeds>
        </securitiesSoldInPast3Months>
        <noticeSignature>
            <noticeDate>07/01/2025</noticeDate>
            <planAdoptionDates/>
            <signature>/s/ Sahil Vikas Kirpekar</signature>
        </noticeSignature>
    </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
